{"schema_version":"secwatch.filing_event.v1","accession":"0000920148-23-000035","form_type":"8-K/A","ticker":"LH","cik":"0000920148","company_name":"LABCORP HOLDINGS INC.","filed_at":"2023-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.808312+00:00","generated_at":"2026-06-15T19:03:36.650597+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Labcorp appoints Mark Schroeder EVP, President Diagnostics & COO; awards equity valued at $500k","bullets":["Mark Schroeder appointed EVP, President Diagnostics & Chief Operations Officer effective May 1, 2023.","Base salary increased to $650,000.","Received RSU and option awards each valued at $100,000, and a performance share award valued at $300,000."],"urls":{"canonical":"https://secwatch.observer/filing/0000920148-23-000035","json":"https://secwatch.observer/filing/0000920148-23-000035.json","markdown":"https://secwatch.observer/filing/0000920148-23-000035.md","text":"https://secwatch.observer/filing/0000920148-23-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000035/0000920148-23-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000035/lh-20230501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T19:03:36.650597+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b444f66341","claim":"Mark S. Schroeder was appointed as Executive Vice President, President Diagnostics & Chief Operations Officer at LABCORP HOLDINGS INC..","evidence_excerpt":"on May 4, 2023, Labcorp announced that Mark S. Schroeder, the current Executive Vice President, and President, Diagnostics Laboratory Operations and Global Supply Chain of Labcorp, a named executive officer, has been appointed to the position of Executive Vice President, President Diagnostics & Chief Operations Officer, effective May 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/920148/000092014823000035/0000920148-23-000035-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President, President Diagnostics & Chief Operations Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}